Jiang Yi-bo, Chen Li-juan, Tang Yao-liang, Ma Gen-shan, Qi Chun-mei, Zhu Qi, Zhang Xiao-li, Yao Yu-yu, Liu Nai-feng, Shen Cheng-xing
Department of Cardiology, Zhongda Hospital, Southeast University, Nanjing 210009, China.
Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Aug;37(8):692-5.
To observe the effect of intracoronary transfer of autologous HO-1 overexpressed MSCs in porcine model of myocardial ischemia (1 h)/reperfusion.
Apoptosis was assayed and cytokine concentrations in supernatant were measured in cells exposed to hypoxia-reoxygen in vitro. In vivo, Chinese male mini-pigs were allocated to the following treatment groups: control group (saline), MSCs group (MSCs), MSCs transfected with pcDNA3.1-nHO-1 (HO-1-MSCs). 1 x 10(7) of autologous stem cells or identical volume of saline was injected intracoronary into porcine hearts 1 h after ischemia. MRI assay and postmortem analysis were assessed 3 months after stem cell transplantation.
In vitro, cell apoptosis rate post hypoxia-reoxygen was significantly reduced in HO-1-MSCs group (30.30% +/- 7.64%) compared with that in MSCs group (56.93% +/- 4.68%, P < 0.001) and LacZ-MSCs group (55.88% +/- 4.38%, P < 0.001), VEGF was also significantly upregulated in HO-1-MSCs group [(768.44 +/- 78.38) pg/ml] compared with that in MSCs group [(555.27 +/- 67.67) pg/ml, P < 0.001] and LacZ-MSCs group [(522.97 +/- 71.45) pg/ml, P < 0.001]. In vivo, cardiac function was significantly improved in both MSCs transplantation groups compared to saline group (all P < 0.05 vs.saline) and the left ventricular ejection fraction was significantly higher in HO-1-MSCs group compared with that in MSCs group at 3 months after transplantation (53.50% +/- 2.09% vs. 49.54% +/- 2.74%, P = 0.017), capillary density in the peri-infarct area was also significantly higher in HO-1-MSC group than that in MSCs group [(14.59 +/- 2.39)/HPF vs. (11.78 +/- 2.48)/HPF, P = 0.033].
Efficacy of HO-1 overexpressed MSCs on improving cardiac function and promoting angiogenesis was greater than those by MSCs in this porcine ischemia/reperfusion model.
观察自体过表达HO-1的间充质干细胞(MSCs)冠状动脉内移植对猪心肌缺血(1小时)/再灌注模型的影响。
在体外对暴露于缺氧/复氧的细胞进行凋亡检测,并测定上清液中的细胞因子浓度。在体内,将中国雄性小型猪分为以下治疗组:对照组(生理盐水)、MSCs组(MSCs)、转染pcDNA3.1-nHO-1的MSCs组(HO-1-MSCs)。缺血1小时后,将1×10⁷个自体干细胞或相同体积的生理盐水冠状动脉内注射到猪心脏中。干细胞移植3个月后进行磁共振成像(MRI)检测和尸检分析。
在体外,与MSCs组(56.93%±4.68%)和LacZ-MSCs组(55.88%±4.38%)相比,HO-1-MSCs组缺氧/复氧后的细胞凋亡率显著降低(30.30%±7.64%,P<0.001);与MSCs组((555.27±67.67)pg/ml)和LacZ-MSCs组((522.97±71.45)pg/ml)相比,HO-1-MSCs组的血管内皮生长因子(VEGF)也显著上调((768.44±78.38)pg/ml,P<0.001)。在体内,与生理盐水组相比,两个MSCs移植组的心脏功能均显著改善(与生理盐水组相比,均P<0.05),移植3个月后,HO-1-MSCs组的左心室射血分数显著高于MSCs组(53.50%±2.09%对49.54%±2.74%,P=0.017),HO-1-MSC组梗死周边区域的毛细血管密度也显著高于MSCs组((14.59±2.39)/高倍视野对(11.78±2.48)/高倍视野,P=0.033)。
在该猪缺血/再灌注模型中,过表达HO-1的MSCs改善心脏功能和促进血管生成的效果优于MSCs。